Newsroom Stories

Douglas Wiens in Arts & Sciences led one of the first seismic studies of the Patagonian Andes, where glaciers are melting at some of the fastest rates on the planet. The team discovered and described a key link between ice mass loss, uplift and a gap between tectonic plates.

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine researchers.

School of Medicine researchers are launching a phase 2 clinical trial to study whether using medication to treat sleep problems in older adults can reduce signs of early Alzheimer’s disease.

Researchers in the lab of Peng Bai at the McKelvey School of Engineering have discovered the key to making a stable, safe battery.

James Wertsch, an expert on Russia and international affairs, analyzes Vladimir Putin’s motivation in attacking Ukraine. He says that Putin sees Russia’s mission as aiming to triumph over democracy and encourage the rise of Christian fascism everywhere.

Undergraduate tuition will be $59,420 for the 2022-23 academic year — a $1,670 (2.9%) increase over the 2021-22 academic tuition of $57,750, announced Amy B. Kweskin, executive vice chancellor for finance and chief financial officer.

Funded by a $33.1 million grant from the National Institute on Aging, researchers from the School of Medicine and other institutions have launched a large study that investigates just what keeps our brains sharp as we age and what contributes to cognitive decline.

Interdisciplinary research from Washington University in St. Louis has uncovered a pattern in the tics associated with Tourette syndrome.

Fans of Bears men’s basketball are encouraging more people to join them at the Field House to cheer on the team. The play is exciting and the players — including Justin Hardy, who is fighting Stage 4 stomach cancer — are inspiring. The Bears close the regular season Saturday, Feb. 26.

Using mass spectrometry, Washington University School of Medicine researchers have developed a blood test that is up to 93% accurate at identifying people at risk of Alzheimer’s dementia. The findings suggest that the test should be considered for routine screening and diagnosis.